MAPT and Alzheimer disease: These PTMs are elevated 2.8‐fold to 3.5‐fold in AD relative to NC (1.7‐ to 2.1‐fold even after adjustment for increased aggregation in AD), only in Aβ‐ or tau‐IP aggregates but not in total aggregates.